These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3667662)

  • 21. Topical cerium nitrate prevents postburn immunosuppression.
    Peterson VM; Hansbrough JF; Wang XW; Zapata-Sirvent R; Boswick JA
    J Trauma; 1985 Nov; 25(11):1039-44. PubMed ID: 4057291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal correlation of impaired immune response after thermal injury with susceptibility to infection in a murine model.
    Moss NM; Gough DB; Jordan AL; Grbic JT; Wood JJ; Rodrick ML; Mannick JA
    Surgery; 1988 Nov; 104(5):882-7. PubMed ID: 3263707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The beneficial effect of granulocyte colony-stimulating factor (G-CSF) in combination with gentamicin on survival after Pseudomonas burn wound infection.
    Silver GM; Gamelli RL; O'Reilly M
    Surgery; 1989 Aug; 106(2):452-5; discussion 455-6. PubMed ID: 2474866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of suppressed cell-mediated immunity in burned mice with histamine-2 receptor antagonist drugs.
    Hansbrough JF; Zapata-Sirvent R; Bender EM; Peterson V
    J Surg Res; 1985 Aug; 39(2):150-6. PubMed ID: 4021474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucan phosphate treatment attenuates burn-induced inflammation and improves resistance to Pseudomonas aeruginosa burn wound infection.
    Lyuksutova OI; Murphey ED; Toliver-Kinsky TE; Lin CY; Cui W; Williams DL; Sherwood ER
    Shock; 2005 Mar; 23(3):224-32. PubMed ID: 15718919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effect of cimetidine against Pseudomonas aeruginosa: infection in an experimental burned mouse model.
    Zehavi-Willner T; Markenson J; Pinto M
    Isr J Med Sci; 1986 Jun; 22(6):460-2. PubMed ID: 3759431
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of low dose recombinant interleukin 2 plus indomethacin on mortality after sepsis in a murine burn model.
    Horgan PG; Mannick JA; Dubravec DB; Rodrick ML
    Br J Surg; 1990 Apr; 77(4):401-4. PubMed ID: 2340389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoration of immunity in burned mice by cimetidine.
    Bender EM; Hansbrough JF; Zapata-Sirvent R; Sullivan J; Claman HN
    J Trauma; 1985 Feb; 25(2):131-7. PubMed ID: 3156251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The deleterious effects of high dose cimetidine in acute thermal injury.
    Searcy RM; Cone JB; Bowser BH; Caldwell FT
    Burns Incl Therm Inj; 1982 Sep; 9(1):62-5. PubMed ID: 7172078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thermal injury-induced non-specific resistance to fatal Pseudomonas aeruginosa burn-infection in mice.
    Pinto M; Zehavi-Willner T
    Jpn J Exp Med; 1989 Oct; 59(5):189-96. PubMed ID: 2559218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restoration of natural IgM production from liver B cells by exogenous IL-18 improves the survival of burn-injured mice infected with Pseudomonas aeruginosa.
    Kinoshita M; Shinomiya N; Ono S; Tsujimoto H; Kawabata T; Matsumoto A; Hiraide H; Seki S
    J Immunol; 2006 Oct; 177(7):4627-35. PubMed ID: 16982901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium antagonists improve cardiac mechanical performance after thermal trauma.
    Horton JW; White DJ; Maass D; Sanders B; Thompson M; Giroir B
    J Surg Res; 1999 Nov; 87(1):39-50. PubMed ID: 10527702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of thermal injury and immunosuppression on the dissemination of Candida albicans from the mouse gastrointestinal tract.
    Ekenna O; Fader RC
    J Burn Care Rehabil; 1989; 10(2):138-45. PubMed ID: 2651449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge.
    Neely AN; Holder IA; Wiener-Kronish JP; Sawa T
    Burns; 2005 Mar; 31(2):153-8. PubMed ID: 15683685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of effect of enteral antibiotics on the post-burn hypermetabolic response.
    Waymack JP; Trocki O; Alexander JW; Heyd TJ; Warden GD
    Burns Incl Therm Inj; 1987 Oct; 13(5):365-70. PubMed ID: 3427493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Candida infection in massively burned patients.
    Desai MH; Herndon DN; Abston S
    J Trauma; 1987 Oct; 27(10):1186-8. PubMed ID: 3669112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary clinical experiences with the use of immunomodulators in burns.
    Donati L; Lazzarin A; Signorini M; Candiani P; Klinger M; Moroni M
    J Trauma; 1983 Sep; 23(9):816-31. PubMed ID: 6194307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cimetidine effects on the immunosuppression induced by burn injury.
    Kokhaei P; Barough MS; Hassan ZM
    Int Immunopharmacol; 2014 Sep; 22(1):273-6. PubMed ID: 25038319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant neutral endopeptidase decreases oedema in the skin of burned guinea-pigs.
    Neely AN; Imwalle AR; Holder IA
    Burns; 1996 Nov; 22(7):520-3. PubMed ID: 8909751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the immunosuppressive effect of burned tissue in an animal model.
    Hansbrough JF; Zapata-Sirvent R; Peterson V; Wang X; Bender E; Claman H; Boswick J
    J Surg Res; 1984 Nov; 37(5):383-93. PubMed ID: 6492780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.